Filter Results:
(990)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
- 08 Mar 2017
- News
Safe, Secure, and Prosperous
protect our nation by stopping all of the threats that might affect us: national security, criminality, human trafficking, and illicit drugs crossing our borders. “The job that I have has responsibility for the intelligence capability and... View Details
- 01 Jun 2016
- News
@Soldiers Field
diverse, outstanding future leaders and who will go on to make a real difference in the world.” Baker Library’s Historical Collections acquired a trove of archival materials from Genzyme, one of the world’s leading biotechnology firms. A pioneer in the development of... View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
for everyone and also highlighted the important link between research, discovery, and cure." The GPP is a statewide prevention program aimed at reducing the use of dangerous drugs among teens and young adults through awareness campaigns,... View Details
- 02 Feb 2021
- Blog Post
Finding My Focus in Health care Amidst a Global Pandemic
can redefine the Health care industry and sparked my interest in exploring how the public and private sectors can work together to improve patient outcomes. With the summer internship search heating up, I am excited to explore opportunities as an intern at the Food and... View Details
- 01 Mar 2017
- News
Alumni Take Cold Calls in New York City
focused on 23andMe, whose sale of genetic testing kits directly to consumers was challenged by the Food & Drug Administration. Quelch, who coauthored the case, is also on the faculty of the Harvard T.H. Chan School of Public Health. The... View Details
- 20 Dec 2018
- Research & Ideas
Most Popular Stories and Research Papers of 2018
Cirrus Foroughi, and Barbara Larson. Developing Novel Drugs This paper by Joshua Krieger and colleagues contributes to our understanding of how financing constraints affect the direction of innovation in View Details
Keywords: by Sean Silverthorne
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
he made the decision to continue investing in longer-term research rather than short-term profit after Merck took its blockbuster drug Vioxx off the market in September 2004. "He believed that the only way for Merck to recover was to... View Details
- Profile
Henry McCance
a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had spent 40 years as eyewitness to advances in technology that changed the world at... View Details
- Web
Market Perspectives - Course Catalog
cases explore concrete situations that highlight the challenges and tradeoffs of decision-makers. Issues explored include: education, urban development, illegal drugs, rent control, housing, drug pricing, racial references, corporate... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
health information network are expected to be substantial. A RAND Corporation study estimates savings to the U.S. health-care system of up to $162 billion a year by improving medical-care delivery, reducing medical errors and adverse drug... View Details
- Portrait Project
Sarah Assayag
I would become the first colony settler on Earth 2.0, develop drugs that would allow humans to become immortal, and create an android that would fall asleep by counting electric sheep. My 8-year-old self, inspired by science fiction,... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
biotech companies—as a function of cost, time, and failure modes—tend to risk pivot on one program, one clinical trial, one outcome,” he observes. “Our company is the leader in mining muscle biology for drug discoveries that translate... View Details
Keywords: Deborah Blagg
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- 24 Jan 2025
- News
The Network Effect
Karan Mathur (left) and Dina Model (Illustration by Gisela Goppel) When Dina Model and Karan Mathur (both MBA 2015) met through mutual friends during their first year at HBS, neither was envisioning a future business deal. “We didn’t realize that we had shared... View Details
- 23 Mar 2010
- First Look
First Look: March 23
Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
- Profile
Terrance McGuire
venture created by four post-docs from The Whitehead Institute, which is now a public company with a drug on the market. He helped rescue deCODE from bankruptcy and oversaw its sale to Amgen. For more than 20 years, McGuire has also... View Details
- 30 Sep 2022
- News
Scaling Hope
collection of essays that D’Antonio hopes will help other parents, he writes of what he wishes he’d known in the beginning: “I wish I had known that there was hope, a lot of hope, and that recovery was likely to happen for my son. I wish I had known that my son could... View Details
- 01 Dec 2006
- News
Faculty Books
from its character as a science-based business. This poses three challenges: how to finance risky investments with long time horizons for R&D; keep pace with advances in drug knowledge; and integrate capabil-ities across the spectrum of... View Details
- 01 Mar 2011
- News
Wyss Celebrated for Career, Conservation
orthopedic and trauma surgery. He continues to serve as chairman. In recognition of his career, the HBS Health Industry Alumni Association presented Wyss with the Beatrice D. Ellerin Alumni Achievement Award at its annual conference in November (see article "Fixing... View Details